Literature DB >> 22642242

Prevalence of occult celiac disease in healthy Iranian school age children.

Fatemeh Farahmand1, Mohammad Mehdi Mir-Nasseri, Touran Shahraki, Fatemeh Yourdkhani, Sayeh Ghotb, Vajiheh Modaresi, Gholam Reza Khatami.   

Abstract

BACKGROUND: Several studies have shown the prevalence of celiac disease (CD) to be around 1% in Iran, which is similar to the worldwide prevalence. There is scant information on occult CD in apparently healthy school age children. This study, as the first such study in Iran, aims to determine the prevalence of occult CD in healthy Iranian school age children.
METHODS: In this cross-sectional study, we screened healthy school age children for CD by serum IgA and IgA anti-tissue transglutaminase antibody (tTG) levels. Measurement of these antibodies was by enzyme linked immunosorbent assay. A recheck of positive tTG tests was performed and patients who tested positive underwent endoscopic duodenal biopsies. The biopsy samples were scored according to the Marsh classification by an experienced pathologist.
RESULTS: A total of 634 children (314 males, 320 females; mean age: 12.8 years) were included in the study. All children and/or their parents completed a questionnaire and children underwent an initial physical examination to determine study eligibility. Positive serum tTG was noted in 3 (0.5%; 2 females) out of 634 patients. Duodenal biopsies were consistent with CD in these 3 subjects. The mean age of patients with CD was 14.3 years (range: 12-17 years). The female to male ratio was 2:1. These cases had no signs and symptoms, but a gluten-free diet was recommended according to pathologic changes in their small bowels and results of the tTG test.
CONCLUSION: The prevalence of occult CD in these children is 0.5%, which is half of the prevalence of CD in Iranian adults. The anti-tTG concentration at initial serological CD screening is highly informative in determining occult cases of CD. The question is whether all non-symptomatic cases should be treated with a gluten-free diet or not.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22642242     DOI: 012156/AIM.005

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  7 in total

1.  Frequency of Celiac Disease In Children With Chronic Functional Constipation in Shiraz-Iran.

Authors:  Seyed Mohsen Dehghani; Zahra Ehsaei; Naser Honar; Hazhir Javaherizadeh
Journal:  Middle East J Dig Dis       Date:  2015-07

2.  Serological Evaluation of Celiac Disease in Children with Congenital Heart Defect; A Case Control Study.

Authors:  Iraj Shahramian; Seyed Mohsen Dehghani; Mahmood Haghighat; Noor Mohammad Noori; Alireza Teimouri; Elham Sharafi; Manijeh Kalili; Gholamreza Kalvandi
Journal:  Middle East J Dig Dis       Date:  2015-04

3.  Celiac disease in Iran: a systematic review and meta-analysis.

Authors:  Roghayeh Mohammadibakhsh; Rahim Sohrabi; Morteza Salemi; Masood Taheri Mirghaed; Masoud Behzadifar
Journal:  Electron Physician       Date:  2017-03-25

4.  Prevalence of celiac disease in low and high risk population in Asia-Pacific region: a systematic review and meta-analysis.

Authors:  Sara Ashtari; Hadis Najafimehr; Mohamad Amin Pourhoseingholi; Kamran Rostami; Hamid Asadzadeh-Aghdaei; Mohammad Rostami-Nejad; Mostafa Rezaei Tavirani; Meysam Olfatifar; Govind K Makharia; Mohammad Reza Zali
Journal:  Sci Rep       Date:  2021-01-27       Impact factor: 4.379

5.  Prevalence of celiac disease among symptom-free children from the Eastern Province of Saudi Arabia.

Authors:  Maher M Al Hatlani
Journal:  Saudi J Gastroenterol       Date:  2015 Nov-Dec       Impact factor: 2.485

6.  Prevalence of celiac disease in healthy Iranian school children.

Authors:  Mahmood Dhahir Al-Mendalawi
Journal:  Ann Saudi Med       Date:  2013 Sep-Oct       Impact factor: 1.526

7.  Genetic susceptibility for celiac disease is highly prevalent in the Saudi population.

Authors:  Abdulrahman Al-Hussaini; Hanan Alharthi; Awad Osman; Nezar Eltayeb-Elsheikh; Aziz Chentoufi
Journal:  Saudi J Gastroenterol       Date:  2018 Sep-Oct       Impact factor: 2.485

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.